Correlation Between Spyre Therapeutics and Mind Medicine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Mind Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Mind Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Mind Medicine, you can compare the effects of market volatilities on Spyre Therapeutics and Mind Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Mind Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Mind Medicine.

Diversification Opportunities for Spyre Therapeutics and Mind Medicine

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Spyre and Mind is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Mind Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mind Medicine and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Mind Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mind Medicine has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Mind Medicine go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Mind Medicine

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Mind Medicine. But the stock apears to be less risky and, when comparing its historical volatility, Spyre Therapeutics is 1.57 times less risky than Mind Medicine. The stock trades about -0.18 of its potential returns per unit of risk. The Mind Medicine is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  622.00  in Mind Medicine on August 24, 2024 and sell it today you would earn a total of  134.00  from holding Mind Medicine or generate 21.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Spyre Therapeutics  vs.  Mind Medicine

 Performance 
       Timeline  
Spyre Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Spyre Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Spyre Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Mind Medicine 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Mind Medicine are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating primary indicators, Mind Medicine exhibited solid returns over the last few months and may actually be approaching a breakup point.

Spyre Therapeutics and Mind Medicine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spyre Therapeutics and Mind Medicine

The main advantage of trading using opposite Spyre Therapeutics and Mind Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Mind Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mind Medicine will offset losses from the drop in Mind Medicine's long position.
The idea behind Spyre Therapeutics and Mind Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios